Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

Molecular and Cellular Biology

Volumn 20, Issue 16, 2000, Pages 6147-6158

  Franklin, D S ^a   Godfrey, V L ^a   O'Brien, D A ^a   Deng, C ^a   Xiong, Y ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PHOSPHOTRANSFERASE; PROTEIN P21; PROTEIN P27;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE SPECIFICITY;

ANIMALS; CELL DIVISION; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; ORGAN SPECIFICITY;

ANIMALIA; MAMMALIA;

EID: 0033864297     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.16.6147-6158.2000     Document Type: Article

References (43)

1. Atm-deficient mice: A paradigm of ataxia telangiectasia
2. Differentiation of adult Leydig cells
3. Radiation-induced cell cycle arrest compromised by p21 deficiency
4. Familial multiple endocrine neoplasia syndromes: Components, classification, and nomenclature
5. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
6. 1 checkpoint control
7. Mice deficient for p53 are developmentally normal but susceptible to spontaneous turnouts
8. WAF1, a potential mediator of p53 tumor suppression
9. The murine gene p27(Kip1) is haplo-insufficient for tumor suppression
10. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
11. CDK inhibitors p18(INK4c) and p27(KIP1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis
12. Induction of p18(INK4c) and its predominant association with CDK4 and CDK6 during myogenic differentiation
13. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice
14. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin
15. Monoclonal antibodies against rat Leydig cell surface antigen
16. A cell cycle regulator potentially involved in genesis of many tumor types
17. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19(ARF)
18. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
19. Chromosome 11q13 abnormalities in human cancer
20. p53, The cellular gatekeeper for growth and division
21. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53
22. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
23. RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb(+/-) mice
24. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
25. Amplification of a gene encoding a p53-associated protein in human sarcomas
26. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice
27. Assay for cyclin D-dependent kinases 4 and 6
28. The MEN II syndromes and the role of the ret proto-oncogene
29. Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene
30. Role of the INK4a locus in tumor suppression and cell mortality
31. Cancer cell cycle
32. Tumor surveillance via the ARF-p53 pathway
33. Cellular localization and regulation of expression of testicular estrogen sulfotransferase
34. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
35. The retinoblastoma protein and cell cycle control
36. Cooperative tumorigenic effects of germline mitations in Rb and p53
37. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation
38. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma
39. Ablation of the CDK inhibitor p57(KIp1) results in increased apotosis and delayed differentiation during mouse development
40. Altered cell differentiation and proliferation in mice lacking p57(KIP2) indicates a role in Beckwith-Wiedemann syndrome
41. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development
42. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step